Advertisement
Article| Volume 74, ISSUE 4, P1187-1195, April 1991

Download started.

Ok

Enhancement of Immune Response in Peyer's Patch Cells Cultured with Bifidobacterium breve

Open ArchiveDOI:https://doi.org/10.3168/jds.S0022-0302(91)78272-6
Enhancement of Immune Response in Peyer's Patch Cells Cultured with Bifidobacterium breve
Previous ArticleA Rapid Method for Laboratory Preparation of High Solids Casein and Caseinate Dispersions
Next ArticleRelationship Between Bile Tolerance and the Presence, of a Ruthenium Red Staining Layer on Strains, of Lactobacillus acidophilus1
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Bifidobacterium breve, included in fermented milk, was tested for adjuvanticity and mitogenicity using cells of mouse Peyer's patch, one of the gut-associated lymphoid tissues.
      Addition of B. breve enhanced antilipopolysaccharide antibody production in Peyer's patch cells and also anti-sheep red blood cell plaque-forming cells in Peyer's patch cells cultured with sheep red blood cells.
      Furthermore, addition of B. breve accelerated proliferation of Peyer's patch cells, particularly B cells. In BALB/c mice, enhancement of proliferation by B. breve was also found in Peyer's patch cells from nude mice and a B cell-enriched fraction, including both the B cell fraction and plastic-adherent cells. Enhancement was not found in the fraction in which Sephadex G10-adherent and carbonyl-iron phagocytic cells were excluded from Peyer's patch cells or in a pure B cell fraction in which plastic-adherent cells were excluded from the B cell-enriched fraction of Peyer's patch cells. The proliferation of B cells was enhanced when the supernatant of plastic-adherent cells cultured with B. breve was added. It is concluded that B. breve activated plastic-adherent cells and that these cells secreted a soluble factor that enhanced proliferation of B cells.

      Key words

      Abbreviation key:

      CI (carbonyl-iron), CW (cell walls), FBS (fetal bovine serum), G10 (Sephadex G10), LPS (lipopolysaccharide), MEM (Minimum Essential Medium), PAC (plastic-adherent cells), PFC (plaque-forming cells), PG (peptidoglycan), PP (Peyer's patch), SI (stimulation index), SRBC (sheep red blood cells)

      References

        • Andre C.
        • Lambert R.
        • Bazin H.
        • Heremans J.F.
        Interference of oral immunization with the intestinal absorption of heterologous albumin.
        Eur. J. Immunol. 1974; 4: 701
        • Araki Y.
        • Nakatani T.
        • Nakayama K.
        • Ito E.
        Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme-resistant cell walls from Bacillus cereus.
        J. Biol. Chem. 1972; 247: 6312
        • Bazin R.
        • Lemieux R.
        Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.
        J. Immunol. 1987; 139: 780
        • Cunningham A.J.
        • Szenberg A.
        Further improvements in the plaque technique for detecting single antibody forming cells.
        Immunology. 1968; 14: 599
        • Damais C.
        • Bona C.
        • Chedid L.
        • Fleck J.
        • Nauciel C.
        • Martin J.P.
        Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.
        J. Immunol. 1975; 115: 268
        • Damais C.
        • Parant M.
        • Chedid L.
        Non-specific activation of murine spleen cells in vitro by synthetic immunoadjuvant (N-acetil-muramyl-L-alanyl-D-isoglutamine).
        Cell. Immunol. 1977; 34: 49
        • Dziarski R.
        • Dziarski A.
        Mitogenic activity of staphylococcal peptidoglycan.
        Infect Immun. 1979; 23: 706
        • Elson C.O.
        • Ealding W.
        • Lefkowitz J.
        A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretion.
        J. Immunol. Methods. 1984; 67: 101
        • Forsgren A.
        • Svedjelund A.
        • Wigzell H.
        Lymphocyte stimulation by protein A of Staphylococcus aureus.
        Eur. J. Immunol. 1976; 6: 207
        • Frangakis M.V.
        • Koopman W.J.
        • Kiyono H.
        • Michalek S.M.
        • McGhee J.R.
        An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages.
        J. Immunol. Methods. 1982; 48: 33
        • Freedman A.S.
        • Freeman G.
        • Whitman J.
        • Segil J.
        • Daley J.
        • Nadler L.M.
        Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation.
        J. Immunol. 1988; 141: 3398
        • Hirano T.
        • Yasukawa K.
        • Harada H.
        • Taga T.
        • Watanabe Y.
        • Matsuda T.
        • Kashiwamura S.
        • Nakajima K.
        • Koyama K.
        • Iwamatsu A.
        • Sakiyama F.
        • Matsui H.
        • Takahara Y.
        • Taniguchi T.
        • Kishimoto T.
        Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.
        Nature (Lond.). 1986; 324: 73
        • Homma N.
        Intestinal flora of infants and resistance to infection.
        Jpn. J. Pediatr. 1974; 27: 1266
        • Janossy G.
        • Greaves M.F.
        Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.
        Clin. Exp. Immunol. 1971; 9: 483
        • Jelinek D.F.
        • Lipsky P.E.
        Enhancement of human B cell proliferation and differentiation by tumor necrosis factor and interleukin 1.
        J. Immunol. 1987; 139: 2970
        • Ly I.A.
        • Mishell R.
        Separation of mouse spleen cells by passage through column of sephadex G-10.
        J. Immunol. Methods. 1974; 5: 239
        • Mage M.G.
        • McHugh L.L.
        • Rothstein T.L.
        Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.
        J. Immunol. Methods. 1977; 15: 47
        • Mishell R.I.
        • Dutton R.W.
        Immunization of dissociated spleen cell cultures from normal mice.
        J. Exp. Med. 1967; 126: 423
        • Mitsuoka T.
        • Kaneuchi C.
        Ecology of the bifidobacteria.
        Am. J. Clin. Nutr. 1977; 30: 1799
        • Nordan R.P.
        • Pumphrey J.G.
        • Rudikoff S.
        Purification and NH2-terminal sequence of a plasmacy-toma growth factor derived from the murine macrophage cell line P388D1.
        J. Immunol. 1987; 139: 813
        • Owen R.L.
        Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study.
        Gastroenterology. 1977; 72: 440
        • Peavy D.L.
        • Adler W.H.
        • Smith R.T.
        The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes.
        J. Immunol. 1970; 105: 1453
        • Perdigon G.
        • Nader de Macias M.E.
        • Alvarez S.
        • Oliver G.
        • Pesce de Ruiz Holgado A.A.
        Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus.
        J. Dairy Sci. 1987; 70: 919
        • Poupard J.A.
        • Husain I.
        • Norris R.F.
        Biology of bifidobacteria.
        Bacteriol. Rev. 1973; 37: 136
        • Sjoberg O.
        • Andersson J.
        • Moller G.
        Requirement for adherent cells in the primary and secondary immune response in vitro.
        Eur. J. Immunol. 1972; 20: 123
        • Stokes C.R.
        • Soothill J.F.
        • Turner M.W.
        Immune exclusion is a function of IgA.
        Nature (Lond.). 1975; 255: 745
        • Tissier M.H.
        La reaction chromophile d’Escherich et le Bacterium coli.
        C. R. Seances Soc. Biol. Fil. 1899; 51: 943
        • Tosato G.
        • Seamon K.B.
        • Goldman N.C.
        • Jones K.D.
        • Pike S.B.
        Monocyte-derived human B-cell growth factor identified as interferon-B2 (BSF-2, IL-6).
        Science. 1988; 239: 502
        • Viljanen M.K.
        • Nunni T.
        • Salminen A.
        Enzyme-linked immunosorbent assay (EUSA) with bacterial sonicate antigen for IgM, IgA and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen.
        J. Infect. Dis. 1983; 148: 715
        • Vink A.
        • Conlie P.G.
        • Wanters P.
        • Nordan R.P.
        • Van Snick J.
        B cell growth and differentiation activity of interleukin-HPl and related murine plas-macytoma growth factors. Synergy with interleufcin 1.
        Eur. J. Immunol. 1988; 18: 607
        • Yamazaki S.
        • Kamimura H.
        • Momose H.
        • Kawashima T.
        • Ueda K.
        Protective effect of Bifidobacterium-monoassociatioa against lethal activity of Escherichia coli.
        Bifidobacteria Microflora. 1982; 1: 55
        • Yasui H.
        • Mike A.
        • Ohwaki M.
        Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration.
        J. Dairy Sci. 1989; 72: 30
        • Yasui H.
        • Yasutake N.
        • Ohwaki M.
        Immunogenicity of Bacteroides isolated from mice: relationship between immunogenicity and cell wall antigens.
        Infect Immun. 1979; 24: 39

      Article info

      Publication history

      Accepted: October 15, 1990
      Received: July 13, 1990

      Identification

      DOI: https://doi.org/10.3168/jds.S0022-0302(91)78272-6

      Copyright

      © 1991 American Dairy Science Association. Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX